Fluke Biomedical, Everett, Wash, has released Ansur 3.0, the largest update to its test automation software platform to date. The company reports that Ansur 3.0 provides new login features, and more customization options and reporting choices than before, among other update features.

According to Fluke, new features and benefits of the Ansur 3.0 release also include customizable authorization levels that allow organizations to set user, author, and administrator credential levels to enhance traceability and manage access. Ansur 3.0 also is said to offer compliance enhancements, allowing users to create their own signature to sign templates and results, a feature that is compliant with the FDA requirement, 21 CFR Part 11. An additional enhancement includes device customizations under test fields, wherein users can specify the number of fields, groups of fields, and field names when creating and modifying Ansur templates.

The update, as described by Fluke, is designed to minimize risk and maximize regulatory compliance. The company says its Ansur Test Automation Software standardizes work and reduces test time to increase productivity and reduce human error in medical device quality assurance testing. With the update, test results are captured electronically and stored digitally in version-controlled records in CMMS or alternative databases of choice.

For more details and to access the Ansur 3.0 update, visit the Fluke Biomedical website.